Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation

Liver Transplantation

Volumn 6, Issue 4, 2000, Pages 443-450

  Krowka, Michael J ^a   Plevak, David J ^a   Findlay, James Y ^a   Rosen, Charles B ^a   Wiesner, Russell H ^a   Krom, Ruud A F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CHILD; CLINICAL ARTICLE; FEMALE; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0033915234     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2000.6356     Document Type: Article

References (35)

1. Coexistent pulmonary and portal hypertension: Morphologic and clinical features
2. Pulmonary vascular disorders in portal hypertension
3. Distinctive clinical features of portopulmonary hypertension
4. Pulmonary hypertension in chronic liver disease
5. Severe pulmonary hypertension in liver transplant candidates
6. Hepatopulmonary syndrome and portopulmonary hypertension: Distinctions and dilemmas
7. Association between primary pulmonary hypertension and portal hypertension: Analysis of patho-physiology, clinical laboratory, and hemodynamic manifestations
8. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics
9. Pulmonary hypertension and liver transplantation
10. Primary pulmonary hypertension: A national prospective study
11. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation
12. Preoperative pulmonary hemodynamics and early mortality after orthotopic heart transplantation: The Pittsburgh experience
13. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
14. Pulmonary hypertension in a patient undergoing liver transplantation
15. Pulmonary artery hypertension complicating anesthesia for liver transplantation
16. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation
17. Single lung versus liver transplantation for the treatment of portopulmonary hypertension - A comparison of two patients
18. Reversibility of pulmonary hypertension after liver transplantation: A case report
19. Resolution of pulmonary hypertension of cirrhosis after liver transplantation
20. Nitric oxide reduces pulmonary hypertension during hepatic transplantation
21. Case report: Delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis
22. Abdominal aortic compression to treat circulatory collapse caused by severe pulmonary hypertension during liver transplantation
23. Orthotopic liver transplantation in a patient with primary pulmonary hypertension
24. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients
25. Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension
26. Successful use of chronic epoprosrenol as a bridge to liver transplantation in severe portopulmonary hypertension
27. Treatment of pulmonary hypertension with inhaled nitric oxide during hepatic transplantation in an adolescent: Reversibility of pulmonary hypertension after transplantation
28. Improvement of pulmonary hypertension after liver transplantation
29. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol
30. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension
31. Moderate primary pulmonary hypertension in patients undergoing liver transplantation
32. Pulmonary platelet aggregates: Possible cause of sudden perioperative death in adults undergoing liver transplantation
33. Effect of orally active prostacyclin analogue on survival of patients with primary pulmonary hypertension
34. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement
35. National database for hepatopulmonary syndrome and portopulmonary hypertension in liver transplant candidates/recipients [letter]